12 PENNS TRAIL, NEWTOWN, PA
Traws Pharma Updates on Ratutrelvir Study and Tivoxavir for Influenza
Completes Enrollment of Ratutrelvir Clinical Study in PAXLOVID®-Eligible and Ineligible COVID-19 Patients
Traws Pharma Files IND for Influenza, Updates on Ratutrelvir COVID-19 Study
Other Events
Executive Compensation Approved - Options and RSUs Granted
Amendment to 2021 Incentive Compensation Plan Approved by Stockholders
Reports Third Quarter 2025 Results and Business Highlights
Changes in Board, Management or Compensation
Notice of Late Filing for Annual Report
Q3
Q2
Q1
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(4)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
PRER14A
Statement of Changes in Beneficial Ownership